Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Fukushima Medical University
With
Human Genome Center, Institute of Medical Science, University of Tokyo
URLC10 and TTK have been identified as cancer specific molecules especially in non small cell lung cancer using genome-wide expression profile analysis by cDNA microarray technique. We have determined the HLA-A\*2402 restricted epitope peptides derived from these molecules. We also tend to use the peptides targeting to tumor angiogenesis. VEGF receptor 1 and 2 are essential targets to tumor angiogenesis, and we identified that peptides derived from these receptors significantly induce the effective tumor specific CTL response in vitro and vivo. According to these findings, in this trial, we evaluate the safety, immunological and clinical response of those peptides.
Age
20–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Disease characteristics
1. Advanced or recurrent non small cell lung cancer